These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11379847)

  • 21. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder.
    Chengappa KN; Ebeling T; Kang JS; Levine J; Parepally H
    J Clin Psychiatry; 1999 Jul; 60(7):477-84. PubMed ID: 10453803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of self-mutilation with olanzapine.
    Garnis-Jones S; Collins S; Rosenthal D
    J Cutan Med Surg; 2000 Jul; 4(3):161-3. PubMed ID: 11003723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open-label study of the treatment efficacy of olanzapine for Tourette's disorder.
    Budman CL; Gayer A; Lesser M; Shi Q; Bruun RD
    J Clin Psychiatry; 2001 Apr; 62(4):290-4. PubMed ID: 11379844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of olanzapine and divalproex for agitation in individuals with profound mental retardation.
    Olson DA; Ingram W; Mann JR
    J Clin Psychopharmacol; 2002 Oct; 22(5):529-30. PubMed ID: 12352281
    [No Abstract]   [Full Text] [Related]  

  • 25. Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.
    Kinon BJ; Basson BR; Gilmore JA; Malcolm S; Stauffer VL
    J Clin Psychiatry; 2000 Nov; 61(11):833-40. PubMed ID: 11105736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose olanzapine for treatment-refractory schizophrenia.
    Sheitman BB; Lindgren JC; Early J; Sved M
    Am J Psychiatry; 1997 Nov; 154(11):1626. PubMed ID: 9356581
    [No Abstract]   [Full Text] [Related]  

  • 27. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
    Breier A; Meehan K; Birkett M; David S; Ferchland I; Sutton V; Taylor CC; Palmer R; Dossenbach M; Kiesler G; Brook S; Wright P
    Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of cervical dystonia by olanzapine.
    Kuniyoshi M; Ohyama S; Otsuka M; Nishi S; Inanaga K; Mori N
    Hum Psychopharmacol; 2003 Jun; 18(4):311-2. PubMed ID: 12766936
    [No Abstract]   [Full Text] [Related]  

  • 29. Clozapine to olanzapine.
    Millson RC; Delva NJ
    Am J Psychiatry; 1999 Jul; 156(7):1121. PubMed ID: 10401476
    [No Abstract]   [Full Text] [Related]  

  • 30. Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study.
    Linehan MM; McDavid JD; Brown MZ; Sayrs JH; Gallop RJ
    J Clin Psychiatry; 2008 Jun; 69(6):999-1005. PubMed ID: 18466045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olanzapine for schizophrenia.
    Med Lett Drugs Ther; 1997 Jan; 39(992):5-6. PubMed ID: 9008682
    [No Abstract]   [Full Text] [Related]  

  • 32. [Olanzapine and cognitive-behavioural group therapy in borderline personality disorder].
    Soler J; Campins MJ; Pérez V; Puigdemont D; Pérez-Blanco E; Alvarez E
    Actas Esp Psiquiatr; 2001; 29(2):85-90. PubMed ID: 11333525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olanzapine in pregnancy.
    Malek-Ahmadi P
    Ann Pharmacother; 2001 Oct; 35(10):1294-5. PubMed ID: 11675867
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment noncompliance with orally disintegrating olanzapine tablets.
    Freudenreich O
    Can J Psychiatry; 2003 Jun; 48(5):353-4. PubMed ID: 12866351
    [No Abstract]   [Full Text] [Related]  

  • 35. Olanzapine in Tourette's disorder.
    Karam-Hage M; Ghaziuddin N
    J Am Acad Child Adolesc Psychiatry; 2000 Feb; 39(2):139. PubMed ID: 10673819
    [No Abstract]   [Full Text] [Related]  

  • 36. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS; Barnhill LJ; Davis JM
    J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Olanzapine. A new antipsychotic agent].
    Bredkjoer SR; Gerlach J
    Ugeskr Laeger; 1997 Nov; 159(48):7160-4. PubMed ID: 9417725
    [No Abstract]   [Full Text] [Related]  

  • 39. Switching clozapine responders to olanzapine.
    Littrell KH; Johnson CG; Hilligoss NM; Peabody CD; Littrell SH
    J Clin Psychiatry; 2000 Dec; 61(12):912-5. PubMed ID: 11206595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olanzapine and panic attacks.
    Etxebeste M; Aragüés E; Malo P; Pacheco L
    Am J Psychiatry; 2000 Apr; 157(4):659-60. PubMed ID: 10739446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.